Hutch News

Hutch News

Stories tagged 'Autoimmune Diseases'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 4, 2018

Increasing access to stem cell transplants; improving survival, QOL for those with scleroderma; biostatistician named chair-elect of AAAS Section on Statistics.

View story >


Stopping Stiff Person Syndrome: Alabama woman turns to stem cell transplant for help

Experimental Fred Hutch treatment aims to ease symptoms of rare, debilitating condition that causes rigid limbs, searing pain

Nov. 18, 2014 | By JoNel Aleccia / Fred Hutch News Service

A young Alabama woman with a rare disorder that leaves her body literally as stiff as a board is the first Fred Hutchinson Cancer Research Center patient to receive a stem cell transplant in hopes of helping – if not curing – her devastating condition.

View story >


Basic Sciences' McLaughlin wins Whitney fellowship

Malik Lab researcher studies the role of genetic evolution in autoimmune disorders

Feb. 13, 2012 | By Colleen Steelquist

Dr. Rick McLaughlin, a postdoctoral researcher in the Fred Hutchinson Cancer Research Center's Malik Lab, has been awarded a prestigious Helen Hay Whitney Foundation research fellowship. He is one of 22 researchers selected for the three-year award from a nationwide search.

View story >


Groh wins $300,000 for lupus research

Dr. Veronika Groh and colleagues find data indicating that a novel subset of immune-system cells may be deficient in active lupus

April 13, 2009

Dr. Veronika Groh, Fred Hutchinson Cancer Research Center Clinical Research Division, is the recipient of a three-year, $100,000 per year grant from the Lupus Research Institute. The grant will fund the study of a novel immunosuppressive CD4 T-cell subset in lupus patients.

View story >


Stem cells from mom may treat diabetic child

Nelson Lab findings could lead to development of new treatments for type 1 diabetes and similar diseases

March 1, 2007 | By DEAN FORBES

View story >


From basic discovery to breakthrough drug

'Determination and persistence' carries a controversial theory to development of drug that prevents inflammation, reduces MS relapse

Feb. 3, 2005 | By BARBARA BERG

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.